These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8096383)
1. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity. Kéri G; Mezö I; Horváth A; Vadász Z; Balogh A; Idei M; Vántus T; Teplán I; Mák M; Horváth J Biochem Biophys Res Commun; 1993 Mar; 191(2):681-7. PubMed ID: 8096383 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity. Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057 [TBL] [Abstract][Full Text] [Related]
3. Novel antitumor peptide hormones and their effect on signal transduction. Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011 [TBL] [Abstract][Full Text] [Related]
4. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity. Teplán I Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357 [TBL] [Abstract][Full Text] [Related]
5. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion. Murphy WA; Taylor JE; Moreau JP; Coy DH Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697 [TBL] [Abstract][Full Text] [Related]
6. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells. Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931 [TBL] [Abstract][Full Text] [Related]
7. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice. Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094 [TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and GH-inhibitory activity of chimeric peptides consisting of GHRP-6 and somatostatin. Dasgupta P; Singh AT; Mukherjee R Biochem Biophys Res Commun; 1999 Jun; 259(2):379-84. PubMed ID: 10362518 [TBL] [Abstract][Full Text] [Related]
9. The tumor-selective somatostatin analog, TT2-32 induces a biphasic activation of phosphotyrosine phosphatase activity in human colon tumor cell line, SW620. Vántus T; Csermely P; Teplán I; Kéri G Tumour Biol; 1995; 16(4):261-7. PubMed ID: 7604207 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor. Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694 [TBL] [Abstract][Full Text] [Related]
11. Conformational study of a series of somatostatin analogues with antitumor and/or GH inhibitory activity. Jaspers H; Horvåth A; Mezö I; Kéri G; Van Binst G Int J Pept Protein Res; 1994 Mar; 43(3):271-6. PubMed ID: 7911792 [TBL] [Abstract][Full Text] [Related]
12. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides). Wang B; Qin C; Zhang C; Jia J; Sun C; Li W Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819 [TBL] [Abstract][Full Text] [Related]
13. Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat. Murphy WA; Heiman ML; Lance VA; Mezo I; Coy DH Biochem Biophys Res Commun; 1985 Nov; 132(3):922-8. PubMed ID: 2866766 [TBL] [Abstract][Full Text] [Related]
14. Biological activities of tyrosine-containing somatostatin analogs on inhibition of secretion of thyrotropin and growth hormone. Ohashi S; Sawano S; Kokubu T; Gondo M; Sakakibara K Endocrinol Jpn; 1976 Oct; 23(5):435-8. PubMed ID: 1009896 [TBL] [Abstract][Full Text] [Related]
15. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Kéri G; Erchegyi J; Horváth A; Mezõ I; Idei M; Vántus T; Balogh A; Vadász Z; Bökönyi G; Seprõdi J; Teplán I; Csuka O; Tejeda M; Gaál D; Szegedi Z; Szende B; Roze C; Kalthoff H; Ullrich A Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12513-8. PubMed ID: 8901613 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Pinski J; Reile H; Halmos G; Groot K; Schally AV Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203 [TBL] [Abstract][Full Text] [Related]
17. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice. Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219 [TBL] [Abstract][Full Text] [Related]
18. Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis. Murray RD; Kim K; Ren SG; Chelly M; Umehara Y; Melmed S J Clin Invest; 2004 Aug; 114(3):349-56. PubMed ID: 15286801 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications. Janecka A; Zubrzycka M Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935 [TBL] [Abstract][Full Text] [Related]
20. Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice. Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K Int J Cancer; 1996 Mar; 65(6):870-4. PubMed ID: 8631606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]